Over the last three years, a significant decrease in child deaths due to malaria was observed, owing to the world's first malaria vaccine. Now 12 African countries are to receive 18 million doses of the malaria vaccine.
The vaccine has the potential to save up to 250,000 lives annually. NmCV-5, unlike current alternatives, provides protection against five main meningococcal strains, including the dangerous emerging X strain.
mRNA-based vaccines for cancer, heart disease, and other conditions could become a significant medical breakthrough.
In the past three years, the number of children hospitalized and deaths due to malaria has decreased significantly in Kenya, thanks to the launch of the world's first malaria vaccine.